-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network, March 29, following the national procurement of coronary stents, the second round of national procurement of high-value consumables is aimed at orthopedics.
The industry makes predictions based on the progress of centralized procurement of coronary stents, and the second round of national procurement may be launched from June to August 2021.
The industry makes predictions based on the progress of centralized procurement of coronary stents, and the second round of national procurement may be launched from June to August 2021.
It is foreseeable that once orthopedics enters the country, the price will inevitably face a big price cut.
The cold winter for orthopedic companies is coming, so what are the "tricks" for companies to cope with centralized procurement?
The cold winter for orthopedic companies is coming, so what are the "tricks" for companies to cope with centralized procurement?
Research and development ceaselessly, seize the "innovation" track
The orthopedics industry has high technical barriers.
In the centralized procurement environment, low-tech enterprises cannot survive.
It is particularly important to attach importance to R&D and master independent core technologies.
In the centralized procurement environment, low-tech enterprises cannot survive.
It is particularly important to attach importance to R&D and master independent core technologies.
Judging from the current innovation direction of orthopedic companies at home and abroad, orthopedic robots are a key area of deployment.
On March 23, 2021, Stryker’s orthopedic surgical robot Mako was approved for total knee replacement indications in China.
It is understood that Mako is currently the only joint surgery robot approved for marketing in China.
It is understood that Mako is currently the only joint surgery robot approved for marketing in China.
Mako SmartRobotics is an innovative solution for many painful knee or hip arthritis.
Mako uses 3D ct-based planning software, so surgeons can understand the details of joint anatomy and create a personalized joint replacement surgery plan.
Mako uses 3D ct-based planning software, so surgeons can understand the details of joint anatomy and create a personalized joint replacement surgery plan.
By guiding doctors during surgery, Mako's AccuStop technology allows surgeons to reduce cuts through precise cutting plans, helping to protect the patient's healthy bones.
On January 19, 2021, Johnson & Johnson DePuy Synthes announced that its orthopedic surgical robot product VELYS has been approved by the FDA for marketing.
This system is the first product of its kind with a portable design and can be placed on the side of the operating table, supporting plug and play.
Can be integrated into any operating room environment.
Its system has good planning ability, optimizes the doctor's surgical procedure, and adapts to the doctor's surgical habits.
This system is the first product of its kind with a portable design and can be placed on the side of the operating table, supporting plug and play.
Can be integrated into any operating room environment.
Its system has good planning ability, optimizes the doctor's surgical procedure, and adapts to the doctor's surgical habits.
And domestic orthopedic companies are also accelerating their deployment in the field of surgical robots.
At present, the domestic deployment of orthopedic robot companies, including Minimally Invasive Medical, Shandong Weigao, Tianzhihang, etc.
At present, the domestic deployment of orthopedic robot companies, including Minimally Invasive Medical, Shandong Weigao, Tianzhihang, etc.
In addition, orthopedic 3D printing that conforms to the development of precision medicine is also very popular.
As a representative cutting-edge technology, 3D printing technology is almost irreplaceable in terms of personalized prostheses and endoplants.
At present, some domestic research results of orthopedics have reached the world's leading level.
As a representative cutting-edge technology, 3D printing technology is almost irreplaceable in terms of personalized prostheses and endoplants.
At present, some domestic research results of orthopedics have reached the world's leading level.
On January 25, 2021, Akcome Medical obtained the registration certificate of three types of medical device for total knee prosthesis approved by the National Medical Products Administration .
This is China's first 3D printed artificial total knee system, marking the era of domestic knee 3D printing coming soon.
This is China's first 3D printed artificial total knee system, marking the era of domestic knee 3D printing coming soon.
In the cold winter of centralized harvesting, not paying attention to innovation may be the last straw to crush the camel.
For long-term development, it is necessary to increase efforts in innovation and research and development, so as to avoid the fate of homogenized products entering the centralized procurement.
In addition to centralized procurement, orthopedic surgical robots and 3D printing may become a new battlefield for orthopedic companies .
The ability to innovate means the improvement of core capabilities and the ability to control market pricing.
For long-term development, it is necessary to increase efforts in innovation and research and development, so as to avoid the fate of homogenized products entering the centralized procurement.
In addition to centralized procurement, orthopedic surgical robots and 3D printing may become a new battlefield for orthopedic companies .
The ability to innovate means the improvement of core capabilities and the ability to control market pricing.
Diversified layout, seeking risk hedging
Orthopedics gathers knives and sharpens, and the single-track mode becomes a weak underbelly.
Eshare Medical Equipment Exchange mentioned in "Chunli Medical Science and Technology Innovation Board IPO "Inquiry", the development of joint single track "The road is long and hindered"", the orthopedic joint is a popular player in the second round of national mining, which is very important for 97 For Chunli Medical, a source of income for joint prostheses, its impact is self-evident.
Whether it can win the blood collection battle is of vital importance to Chunli Medical.
Eshare Medical Equipment Exchange mentioned in "Chunli Medical Science and Technology Innovation Board IPO "Inquiry", the development of joint single track "The road is long and hindered"", the orthopedic joint is a popular player in the second round of national mining, which is very important for 97 For Chunli Medical, a source of income for joint prostheses, its impact is self-evident.
Whether it can win the blood collection battle is of vital importance to Chunli Medical.
In contrast to the multi-track layout of Minimally Invasive Medical, after the national acquisition of coronary stents, the stock price of Minimally Invasive Medical fell briefly, and then recovered and stabilized, mainly due to its multi-track layout.
The products have shifted from the early cardiovascular stents to a diversified business system covering cardiovascular interventions, orthopedic medical devices, heart rate management, aortic and peripheral vascular interventions, and neurointervention products.
Diversified development allows it to hedge against risks in the tide of centralized procurement.
The products have shifted from the early cardiovascular stents to a diversified business system covering cardiovascular interventions, orthopedic medical devices, heart rate management, aortic and peripheral vascular interventions, and neurointervention products.
Diversified development allows it to hedge against risks in the tide of centralized procurement.
Therefore, in the face of the inevitable collection of orthopedics, domestic and foreign orthopedic companies have frequently made efforts to accelerate the diversified industrial layout.
Diversified layout has always been the development path of orthopedic giant Medtronic.
At the 39th annual health care conference of JP Morgan , it was stated that surgical robots, artificial intelligence, neuromodulation fields, emerging markets, etc.
, will be the focus of its efforts in 2021.
So as to continue to strengthen its leading position in the global medical equipment.
At the 39th annual health care conference of JP Morgan , it was stated that surgical robots, artificial intelligence, neuromodulation fields, emerging markets, etc.
, will be the focus of its efforts in 2021.
So as to continue to strengthen its leading position in the global medical equipment.
Weigao, the leading domestic orthopedics company, has also accelerated its diversified development in recent years.
The company's revenue structure has expanded from the first few types of simple consumable products to a combination of various high-value equipment and low-value consumables.
The company's revenue structure has expanded from the first few types of simple consumable products to a combination of various high-value equipment and low-value consumables.
On March 22, Weigao Group recently announced the signing of a strategic cooperation agreement with Roche Diagnostics.
The two parties will cooperate in the field of in vitro diagnostics.
Through strategic cooperation, the company's business will be more diversified in the shortest time.
The diversification of product structure will enable Weigao to enter a broader stage in the future.
The two parties will cooperate in the field of in vitro diagnostics.
Through strategic cooperation, the company's business will be more diversified in the shortest time.
The diversification of product structure will enable Weigao to enter a broader stage in the future.
The revenue structure of Dabo Medical, another leading domestic orthopedic company, is also continuously diversified and optimized.
In addition to core businesses such as trauma and spine, it has also deployed dentistry, joints, sports medicine and other fields, and has a broad future growth space.
In addition to core businesses such as trauma and spine, it has also deployed dentistry, joints, sports medicine and other fields, and has a broad future growth space.
Orthopedics centralized procurement places are coming frequently, and national procurement has also kicked off.
For enterprises, the diversified layout is a safe haven for centralized procurement.
From providing a single product to providing a diversified solution, creating a wider shield will open up more room for growth for orthopedic companies.
For enterprises, the diversified layout is a safe haven for centralized procurement.
From providing a single product to providing a diversified solution, creating a wider shield will open up more room for growth for orthopedic companies.
Extend upward to overcome difficulties in materials science
The development of orthopedics comes with the development of materials science, from the early use of common materials such as steel and copper to the later development of metal alloys, ceramics, polymer materials and even absorbable materials.
Starting from materials, in June 2020, the "Porous Tantalum Bone Repair Material and Implantable Product Development and Clinical Application" project led by Chunli Medical was also approved by the Ministry of Science and Technology as the national key research and development plan for 2020 "Biomedical Material Research and Development".
“Tissue and Organ Repair and Replacement” is a key special project, so as to promote the collaborative innovation of industry, education, research, and medicine.
“Tissue and Organ Repair and Replacement” is a key special project, so as to promote the collaborative innovation of industry, education, research, and medicine.
The development of orthopedic medical devices depends on the innovation of materials, and the current evolution of materials science technology is slow.
For orthopedic companies, overcoming the difficulties of materials science, once a new revolutionary technology appears, it can bring a subversive revolution to the entire orthopedics industry chain, and it will inevitably bring the development of the enterprise to a new height.
For orthopedic companies, overcoming the difficulties of materials science, once a new revolutionary technology appears, it can bring a subversive revolution to the entire orthopedics industry chain, and it will inevitably bring the development of the enterprise to a new height.
The shock wave of centralized mining continues, and the centralized mining of orthopedics track kicks off, and the cold winter has arrived.
In response to centralized procurement, domestic and foreign companies "have their own magical powers.
" These areas that have yet to be fully developed will become "safe havens" for orthopedic companies in centralized procurement.
In response to centralized procurement, domestic and foreign companies "have their own magical powers.
" These areas that have yet to be fully developed will become "safe havens" for orthopedic companies in centralized procurement.
Medical Network, March 29, following the national procurement of coronary stents, the second round of national procurement of high-value consumables is aimed at orthopedics.
The industry makes predictions based on the progress of centralized procurement of coronary stents, and the second round of national procurement may be launched from June to August 2021.
The industry makes predictions based on the progress of centralized procurement of coronary stents, and the second round of national procurement may be launched from June to August 2021.
It is foreseeable that once orthopedics enters the country, the price will inevitably face a big price cut.
The cold winter for orthopedic companies is coming, so what are the "tricks" for companies to cope with centralized procurement?
The cold winter for orthopedic companies is coming, so what are the "tricks" for companies to cope with centralized procurement?
Research and development ceaselessly, seize the "innovation" track
The orthopedics industry has high technical barriers.
In the centralized procurement environment, low-tech enterprises cannot survive.
It is particularly important to attach importance to R&D and master independent core technologies.
In the centralized procurement environment, low-tech enterprises cannot survive.
It is particularly important to attach importance to R&D and master independent core technologies.
Judging from the current innovation direction of orthopedic companies at home and abroad, orthopedic robots are a key area of deployment.
On March 23, 2021, Stryker’s orthopedic surgical robot Mako was approved for total knee replacement indications in China.
It is understood that Mako is currently the only joint surgery robot approved for marketing in China.
It is understood that Mako is currently the only joint surgery robot approved for marketing in China.
Mako SmartRobotics is an innovative solution for many painful knee or hip arthritis.
Mako uses 3D ct-based planning software, so surgeons can understand the details of joint anatomy and create a personalized joint replacement surgery plan.
Mako uses 3D ct-based planning software, so surgeons can understand the details of joint anatomy and create a personalized joint replacement surgery plan.
By guiding doctors during surgery, Mako's AccuStop technology allows surgeons to reduce cuts through precise cutting plans, helping to protect the patient's healthy bones.
On January 19, 2021, Johnson & Johnson DePuy Synthes announced that its orthopedic surgical robot product VELYS has been approved by the FDA for marketing.
This system is the first product of its kind with a portable design and can be placed on the side of the operating table, supporting plug and play.
Can be integrated into any operating room environment.
Its system has good planning ability, optimizes the doctor's surgical procedure, and adapts to the doctor's surgical habits.
This system is the first product of its kind with a portable design and can be placed on the side of the operating table, supporting plug and play.
Can be integrated into any operating room environment.
Its system has good planning ability, optimizes the doctor's surgical procedure, and adapts to the doctor's surgical habits.
And domestic orthopedic companies are also accelerating their deployment in the field of surgical robots.
At present, the domestic deployment of orthopedic robot companies, including Minimally Invasive Medical, Shandong Weigao, Tianzhihang, etc.
At present, the domestic deployment of orthopedic robot companies, including Minimally Invasive Medical, Shandong Weigao, Tianzhihang, etc.
In addition, orthopedic 3D printing that conforms to the development of precision medicine is also very popular.
As a representative cutting-edge technology, 3D printing technology is almost irreplaceable in terms of personalized prostheses and endoplants.
At present, some domestic research results of orthopedics have reached the world's leading level.
As a representative cutting-edge technology, 3D printing technology is almost irreplaceable in terms of personalized prostheses and endoplants.
At present, some domestic research results of orthopedics have reached the world's leading level.
On January 25, 2021, Akcome Medical obtained the registration certificate of three types of medical device for total knee prosthesis approved by the National Medical Products Administration .
This is China's first 3D printed artificial total knee system, marking the era of domestic knee 3D printing coming soon.
This is China's first 3D printed artificial total knee system, marking the era of domestic knee 3D printing coming soon.
In the cold winter of centralized harvesting, not paying attention to innovation may be the last straw to crush the camel.
For long-term development, it is necessary to increase efforts in innovation and research and development, so as to avoid the fate of homogenized products entering the centralized procurement.
In addition to centralized procurement, orthopedic surgical robots and 3D printing may become a new battlefield for orthopedic companies .
The ability to innovate means the improvement of core capabilities and the ability to control market pricing.
For long-term development, it is necessary to increase efforts in innovation and research and development, so as to avoid the fate of homogenized products entering the centralized procurement.
In addition to centralized procurement, orthopedic surgical robots and 3D printing may become a new battlefield for orthopedic companies .
The ability to innovate means the improvement of core capabilities and the ability to control market pricing.
Diversified layout, seeking risk hedging
Orthopedics gathers knives and sharpens, and the single-track mode becomes a weak underbelly.
Eshare Medical Equipment Exchange mentioned in "Chunli Medical Science and Technology Innovation Board IPO "Inquiry", the development of joint single track "The road is long and hindered"", the orthopedic joint is a popular player in the second round of national mining, which is very important for 97 For Chunli Medical, a source of income for joint prostheses, its impact is self-evident.
Whether it can win the blood collection battle is of vital importance to Chunli Medical.
Eshare Medical Equipment Exchange mentioned in "Chunli Medical Science and Technology Innovation Board IPO "Inquiry", the development of joint single track "The road is long and hindered"", the orthopedic joint is a popular player in the second round of national mining, which is very important for 97 For Chunli Medical, a source of income for joint prostheses, its impact is self-evident.
Whether it can win the blood collection battle is of vital importance to Chunli Medical.
In contrast to the multi-track layout of Minimally Invasive Medical, after the national acquisition of coronary stents, the stock price of Minimally Invasive Medical fell briefly, and then recovered and stabilized, mainly due to its multi-track layout.
The products have shifted from the early cardiovascular stents to a diversified business system covering cardiovascular interventions, orthopedic medical devices, heart rate management, aortic and peripheral vascular interventions, and neurointervention products.
Diversified development allows it to hedge against risks in the tide of centralized procurement.
The products have shifted from the early cardiovascular stents to a diversified business system covering cardiovascular interventions, orthopedic medical devices, heart rate management, aortic and peripheral vascular interventions, and neurointervention products.
Diversified development allows it to hedge against risks in the tide of centralized procurement.
Therefore, in the face of the inevitable collection of orthopedics, domestic and foreign orthopedic companies have frequently made efforts to accelerate the diversified industrial layout.
Diversified layout has always been the development path of orthopedic giant Medtronic.
At the 39th annual health care conference of JP Morgan , it was stated that surgical robots, artificial intelligence, neuromodulation fields, emerging markets, etc.
, will be the focus of its efforts in 2021.
So as to continue to strengthen its leading position in the global medical equipment.
At the 39th annual health care conference of JP Morgan , it was stated that surgical robots, artificial intelligence, neuromodulation fields, emerging markets, etc.
, will be the focus of its efforts in 2021.
So as to continue to strengthen its leading position in the global medical equipment.
Weigao, the leading domestic orthopedics company, has also accelerated its diversified development in recent years.
The company's revenue structure has expanded from the first few types of simple consumable products to a combination of various high-value equipment and low-value consumables.
The company's revenue structure has expanded from the first few types of simple consumable products to a combination of various high-value equipment and low-value consumables.
On March 22, Weigao Group recently announced the signing of a strategic cooperation agreement with Roche Diagnostics.
The two parties will cooperate in the field of in vitro diagnostics.
Through strategic cooperation, the company's business will be more diversified in the shortest time.
The diversification of product structure will enable Weigao to enter a broader stage in the future.
The two parties will cooperate in the field of in vitro diagnostics.
Through strategic cooperation, the company's business will be more diversified in the shortest time.
The diversification of product structure will enable Weigao to enter a broader stage in the future.
The revenue structure of Dabo Medical, another leading domestic orthopedic company, is also continuously diversified and optimized.
In addition to core businesses such as trauma and spine, it has also deployed dentistry, joints, sports medicine and other fields, and has a broad future growth space.
In addition to core businesses such as trauma and spine, it has also deployed dentistry, joints, sports medicine and other fields, and has a broad future growth space.
Orthopedics centralized procurement places are coming frequently, and national procurement has also kicked off.
For enterprises, the diversified layout is a safe haven for centralized procurement.
From providing a single product to providing a diversified solution, creating a wider shield will open up more room for growth for orthopedic companies.
For enterprises, the diversified layout is a safe haven for centralized procurement.
From providing a single product to providing a diversified solution, creating a wider shield will open up more room for growth for orthopedic companies.
Extend upward to overcome difficulties in materials science
The development of orthopedics comes with the development of materials science, from the early use of common materials such as steel and copper to the later development of metal alloys, ceramics, polymer materials and even absorbable materials.
Starting from materials, in June 2020, the "Porous Tantalum Bone Repair Material and Implantable Product Development and Clinical Application" project led by Chunli Medical was also approved by the Ministry of Science and Technology as the national key research and development plan for 2020 "Biomedical Material Research and Development".
“Tissue and Organ Repair and Replacement” is a key special project, so as to promote the collaborative innovation of industry, education, research, and medicine.
“Tissue and Organ Repair and Replacement” is a key special project, so as to promote the collaborative innovation of industry, education, research, and medicine.
The development of orthopedic medical devices depends on the innovation of materials, and the current evolution of materials science technology is slow.
For orthopedic companies, overcoming the difficulties of materials science, once a new revolutionary technology appears, it can bring a subversive revolution to the entire orthopedics industry chain, and it will inevitably bring the development of the enterprise to a new height.
For orthopedic companies, overcoming the difficulties of materials science, once a new revolutionary technology appears, it can bring a subversive revolution to the entire orthopedics industry chain, and it will inevitably bring the development of the enterprise to a new height.
The shock wave of centralized mining continues, and the centralized mining of orthopedics track kicks off, and the cold winter has arrived.
In response to centralized procurement, domestic and foreign companies "have their own magical powers.
" These areas that have yet to be fully developed will become "safe havens" for orthopedic companies in centralized procurement.
In response to centralized procurement, domestic and foreign companies "have their own magical powers.
" These areas that have yet to be fully developed will become "safe havens" for orthopedic companies in centralized procurement.
Medical Network, March 29, following the national procurement of coronary stents, the second round of national procurement of high-value consumables is aimed at orthopedics.
The industry makes predictions based on the progress of centralized procurement of coronary stents, and the second round of national procurement may be launched from June to August 2021.
The industry makes predictions based on the progress of centralized procurement of coronary stents, and the second round of national procurement may be launched from June to August 2021.
It is foreseeable that once orthopedics enters the country, the price will inevitably face a big price cut.
The cold winter for orthopedic companies is coming, so what are the "tricks" for companies to cope with centralized procurement?
The cold winter for orthopedic companies is coming, so what are the "tricks" for companies to cope with centralized procurement?
Research and development ceaselessly, seize the "innovation" track
Research and development ceaselessly, seize the "innovation" track The orthopedics industry has high technical barriers.
In the centralized procurement environment, low-tech enterprises cannot survive.
It is particularly important to attach importance to R&D and master independent core technologies.
In the centralized procurement environment, low-tech enterprises cannot survive.
It is particularly important to attach importance to R&D and master independent core technologies.
Judging from the current innovation direction of orthopedic companies at home and abroad, orthopedic robots are a key area of deployment.
On March 23, 2021, Stryker’s orthopedic surgical robot Mako was approved for total knee replacement indications in China.
It is understood that Mako is currently the only joint surgery robot approved for marketing in China.
It is understood that Mako is currently the only joint surgery robot approved for marketing in China.
Mako SmartRobotics is an innovative solution for many painful knee or hip arthritis.
Mako uses 3D ct-based planning software, so surgeons can understand the details of joint anatomy and create a personalized joint replacement surgery plan.
Mako uses 3D ct-based planning software, so surgeons can understand the details of joint anatomy and create a personalized joint replacement surgery plan.
By guiding doctors during surgery, Mako's AccuStop technology allows surgeons to reduce cuts through precise cutting plans, helping to protect the patient's healthy bones.
Healthy, healthy, healthy On January 19, 2021, Johnson & Johnson DePuy Synthes announced that its orthopedic surgical robot product VELYS has been approved by the FDA for marketing.
This system is the first product of its kind with a portable design and can be placed on the side of the operating table, supporting plug and play.
Can be integrated into any operating room environment.
Its system has good planning ability, optimizes the doctor's surgical procedure, and adapts to the doctor's surgical habits.
This system is the first product of its kind with a portable design and can be placed on the side of the operating table, supporting plug and play.
Can be integrated into any operating room environment.
Its system has good planning ability, optimizes the doctor's surgical procedure, and adapts to the doctor's surgical habits.
And domestic orthopedic companies are also accelerating their deployment in the field of surgical robots.
At present, the domestic deployment of orthopedic robot companies, including Minimally Invasive Medical, Shandong Weigao, Tianzhihang, etc.
At present, the domestic deployment of orthopedic robot companies, including Minimally Invasive Medical, Shandong Weigao, Tianzhihang, etc.
In addition, orthopedic 3D printing that conforms to the development of precision medicine is also very popular.
As a representative cutting-edge technology, 3D printing technology is almost irreplaceable in terms of personalized prostheses and endoplants.
At present, some domestic research results of orthopedics have reached the world's leading level.
As a representative cutting-edge technology, 3D printing technology is almost irreplaceable in terms of personalized prostheses and endoplants.
At present, some domestic research results of orthopedics have reached the world's leading level.
On January 25, 2021, Akcome Medical obtained the registration certificate of three types of medical device for total knee prosthesis approved by the National Medical Products Administration .
This is China's first 3D printed artificial total knee system, marking the era of domestic knee 3D printing coming soon.
Medical equipment medical equipment medical equipmentThis is China's first 3D printed artificial total knee system, marking the era of domestic knee 3D printing coming soon.
In the cold winter of centralized harvesting, not paying attention to innovation may be the last straw to crush the camel.
For long-term development, it is necessary to increase efforts in innovation and research and development, so as to avoid the fate of homogenized products entering the centralized procurement.
In addition to centralized procurement, orthopedic surgical robots and 3D printing may become a new battlefield for orthopedic companies .
The ability to innovate means the improvement of core capabilities and the ability to control market pricing.
Enterprise business enterpriseFor long-term development, it is necessary to increase efforts in innovation and research and development, so as to avoid the fate of homogenized products entering the centralized procurement.
In addition to centralized procurement, orthopedic surgical robots and 3D printing may become a new battlefield for orthopedic companies .
The ability to innovate means the improvement of core capabilities and the ability to control market pricing.
Diversified layout, seeking risk hedging
Diversified layout, seeking risk hedging Orthopedics gathers knives and sharpens, and the single-track mode becomes a weak underbelly.
Eshare Medical Equipment Exchange mentioned in "Chunli Medical Science and Technology Innovation Board IPO "Inquiry", the development of joint single track "The road is long and hindered"", the orthopedic joint is a popular player in the second round of national mining, which is very important for 97 For Chunli Medical, a source of income for joint prostheses, its impact is self-evident.
Whether it can win the blood collection battle is of vital importance to Chunli Medical.
Eshare Medical Equipment Exchange mentioned in "Chunli Medical Science and Technology Innovation Board IPO "Inquiry", the development of joint single track "The road is long and hindered"", the orthopedic joint is a popular player in the second round of national mining, which is very important for 97 For Chunli Medical, a source of income for joint prostheses, its impact is self-evident.
Whether it can win the blood collection battle is of vital importance to Chunli Medical.
In contrast to the multi-track layout of Minimally Invasive Medical, after the national acquisition of coronary stents, the stock price of Minimally Invasive Medical fell briefly, and then recovered and stabilized, mainly due to its multi-track layout.
The products have shifted from the early cardiovascular stents to a diversified business system covering cardiovascular interventions, orthopedic medical devices, heart rate management, aortic and peripheral vascular interventions, and neurointervention products.
Diversified development allows it to hedge against risks in the tide of centralized procurement.
The products have shifted from the early cardiovascular stents to a diversified business system covering cardiovascular interventions, orthopedic medical devices, heart rate management, aortic and peripheral vascular interventions, and neurointervention products.
Diversified development allows it to hedge against risks in the tide of centralized procurement.
Therefore, in the face of the inevitable collection of orthopedics, domestic and foreign orthopedic companies have frequently made efforts to accelerate the diversified industrial layout.
Diversified layout has always been the development path of orthopedic giant Medtronic.
At the 39th annual health care conference of JP Morgan , it was stated that surgical robots, artificial intelligence, neuromodulation fields, emerging markets, etc.
, will be the focus of its efforts in 2021.
So as to continue to strengthen its leading position in the global medical equipment.
Health Health CareAt the 39th annual health care conference of JP Morgan , it was stated that surgical robots, artificial intelligence, neuromodulation fields, emerging markets, etc.
, will be the focus of its efforts in 2021.
So as to continue to strengthen its leading position in the global medical equipment.
Weigao, the leading domestic orthopedics company, has also accelerated its diversified development in recent years.
The company's revenue structure has expanded from the first few types of simple consumable products to a combination of various high-value equipment and low-value consumables.
The company's revenue structure has expanded from the first few types of simple consumable products to a combination of various high-value equipment and low-value consumables.
On March 22, Weigao Group recently announced the signing of a strategic cooperation agreement with Roche Diagnostics.
The two parties will cooperate in the field of in vitro diagnostics.
Through strategic cooperation, the company's business will be more diversified in the shortest time.
The diversification of product structure will enable Weigao to enter a broader stage in the future.
The two parties will cooperate in the field of in vitro diagnostics.
Through strategic cooperation, the company's business will be more diversified in the shortest time.
The diversification of product structure will enable Weigao to enter a broader stage in the future.
The revenue structure of Dabo Medical, another leading domestic orthopedic company, is also continuously diversified and optimized.
In addition to core businesses such as trauma and spine, it has also deployed dentistry, joints, sports medicine and other fields, and has a broad future growth space.
Sports, sports, sportsIn addition to core businesses such as trauma and spine, it has also deployed dentistry, joints, sports medicine and other fields, and has a broad future growth space.
Orthopedics centralized procurement places are coming frequently, and national procurement has also kicked off.
For enterprises, the diversified layout is a safe haven for centralized procurement.
From providing a single product to providing a diversified solution, creating a wider shield will open up more room for growth for orthopedic companies.
For enterprises, the diversified layout is a safe haven for centralized procurement.
From providing a single product to providing a diversified solution, creating a wider shield will open up more room for growth for orthopedic companies.
Extend upward to overcome difficulties in materials science
Extend upward to overcome difficulties in materials science The development of orthopedics comes with the development of materials science, from the early use of common materials such as steel and copper to the later development of metal alloys, ceramics, polymer materials and even absorbable materials.
Starting from materials, in June 2020, the "Porous Tantalum Bone Repair Material and Implantable Product Development and Clinical Application" project led by Chunli Medical was also approved by the Ministry of Science and Technology as the national key research and development plan for 2020 "Biomedical Material Research and Development".
“Tissue and Organ Repair and Replacement” is a key special project, so as to promote the collaborative innovation of industry, education, research, and medicine.
“Tissue and Organ Repair and Replacement” is a key special project, so as to promote the collaborative innovation of industry, education, research, and medicine.
The development of orthopedic medical devices depends on the innovation of materials, and the current evolution of materials science technology is slow.
For orthopedic companies, overcoming the difficulties of materials science, once a new revolutionary technology appears, it can bring a subversive revolution to the entire orthopedics industry chain, and it will inevitably bring the development of the enterprise to a new height.
For orthopedic companies, overcoming the difficulties of materials science, once a new revolutionary technology appears, it can bring a subversive revolution to the entire orthopedics industry chain, and it will inevitably bring the development of the enterprise to a new height.
The shock wave of centralized mining continues, and the centralized mining of orthopedics track kicks off, and the cold winter has arrived.
In response to centralized procurement, domestic and foreign companies "have their own magical powers.
" These areas that have yet to be fully developed will become "safe havens" for orthopedic companies in centralized procurement.
In response to centralized procurement, domestic and foreign companies "have their own magical powers.
" These areas that have yet to be fully developed will become "safe havens" for orthopedic companies in centralized procurement.
